71 results
8-K/A
EX-10.1
PTPI
Petros Pharmaceuticals Inc
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
, by and between Keith F. Lavan (“Employee”) and Metuchen Pharmaceuticals, LLC (“Metuchen” or the “Company”).
WHEREAS, Employee is currently employed by Metuchen … as its SVP, Chief Financial Officer; and
WHEREAS, Employee and Metuchen mutually desire to end Employee’s employment with Metuchen and all of its
S-8
EX-99.1
PTPI
Petros Pharmaceuticals Inc
22 Dec 22
Registration of securities for employees
5:03pm
”) and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members … , to render services to the Company or its subsidiaries in accordance with the terms or requirements of his or her employment, engagement as a Non- Employee
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
Pharmaceuticals, Inc. (“Petros”) and Fady Boctor (“Employee”).
WHEREAS, the Company has determined that it is appropriate to award a bonus to Employee … ., Metuchen Pharmaceuticals LLC; provided that in the event that Employee does not remain employment with Petros on the 18th month anniversary of such date
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
4 Mar 22
Departure of Directors or Certain Officers
5:00pm
Andrew Gesek (“Employee”), on the one hand, and Petros Pharmaceuticals, Inc., its affiliates, subsidiaries, and successor entities (“Company … ”), on the other hand (jointly, the “Parties”).
WHEREAS, Employee was employed by Company as an at-will employee;
WHEREAS, Employee and Company entered
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
consideration, the receipt of which is hereby acknowledged, the parties hereto, each of you (“Employee”) and the Company intending to be legally bound … and the Plan or the Option award agreement, the Plan and the Option award agreement shall govern.
E. Employee Benefits. You shall be eligible
DEF 14A
bw4fv3jv
22 Nov 21
Definitive proxy
4:37pm
8-K
EX-3.1
dl84b838bhaackf6t60t
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
S-4
EX-3.1
xklyc7 uydfyld
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
8-K
EX-3.2
4c5idngj9sf pu
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
S-8
cobhajzcxlq7
22 Jan 21
Registration of securities for employees
4:15pm
8-K
EX-99.1
16pzd0043bm uo1gavm6
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
S-8
fcct5jj
22 Dec 22
Registration of securities for employees
5:03pm
424B3
cudi3 kbubeltng
2 Nov 20
Prospectus supplement
12:00am
8-K
EX-10.1
wm4ude aul16m
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm